Technical Analysis for TRDA - Entrada Therapeutics, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Bollinger Band Squeeze | Range Contraction | 0.00% | |
| 20 DMA Support | Bullish | 2.68% | |
| Bollinger Band Squeeze | Range Contraction | 2.68% | |
| NR7 | Range Contraction | 2.68% | |
| Narrow Range Bar | Range Contraction | 2.68% | |
| Down 3 Days in a Row | Weakness | 2.68% | |
| Bollinger Band Squeeze | Range Contraction | 2.15% | |
| Inside Day | Range Contraction | 2.15% | |
| 20 DMA Support | Bullish | 1.85% | |
| Bollinger Band Squeeze | Range Contraction | 1.85% |
| Alert | Time |
|---|---|
| Up 1 ATR | about 22 hours ago |
| 60 Minute Opening Range Breakout | about 22 hours ago |
| Up 3% | about 23 hours ago |
| Rose Above Previous Day's High | about 24 hours ago |
| Up 2% | about 24 hours ago |
Get a Trading Assistant
- Earnings date: 08/06/2024
Entrada Therapeutics, Inc. Description
Entrada Therapeutics is a biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines, Endosomal Escape Vehicles (EEV™), to engage intracellular targets that have long been considered inaccessible and undruggable. The Company’s EEV therapeutics are designed to enable the efficient intracellular delivery of a wide range of therapeutics into a variety of organs and tissues with an improved therapeutic index. Through its proprietary, highly versatile and modular EEV Platform, Entrada is building a robust development portfolio of oligonucleotide-, antibody- and enzyme-based programs for the potential treatment of neuromuscular disease, immunology, oncology and diseases of the central nervous system. The Company’s lead oligonucleotide programs include ENTR-601-44 targeting Duchenne muscular dystrophy (DMD), and a follow-on program targeting myotonic dystrophy type 1 (DM1).
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Biopharmaceutical Disease Medical Genetics Dystrophy Muscular Dystrophy Duchenne Muscular Dystrophy Duchenne Genetic Genealogy Myotonic Dystrophy Neuromuscular Disease
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 18.17 |
| 52 Week Low | 10.915 |
| Average Volume | 126,631 |
| 200-Day Moving Average | 14.94 |
| 50-Day Moving Average | 16.21 |
| 20-Day Moving Average | 17.08 |
| 10-Day Moving Average | 17.19 |
| Average True Range | 0.68 |
| RSI (14) | 60.16 |
| ADX | 19.93 |
| +DI | 25.28 |
| -DI | 14.75 |
| Chandelier Exit (Long, 3 ATRs) | 15.96 |
| Chandelier Exit (Short, 3 ATRs) | 17.70 |
| Upper Bollinger Bands | 18.12 |
| Lower Bollinger Band | 16.04 |
| Percent B (%b) | 0.75 |
| BandWidth | 12.16 |
| MACD Line | 0.34 |
| MACD Signal Line | 0.37 |
| MACD Histogram | -0.0302 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 18.65 | ||||
| Resistance 3 (R3) | 18.62 | 18.24 | 18.48 | ||
| Resistance 2 (R2) | 18.24 | 17.97 | 18.26 | 18.42 | |
| Resistance 1 (R1) | 17.92 | 17.81 | 18.08 | 17.95 | 18.36 |
| Pivot Point | 17.54 | 17.54 | 17.62 | 17.56 | 17.54 |
| Support 1 (S1) | 17.22 | 17.27 | 17.38 | 17.25 | 16.84 |
| Support 2 (S2) | 16.84 | 17.11 | 16.86 | 16.78 | |
| Support 3 (S3) | 16.52 | 16.84 | 16.73 | ||
| Support 4 (S4) | 16.55 |
